Your Source for Venture Capital and Private Equity Financings

VC-funded Company:

Obsidian Therapeutics
1030 Massachusetts Avenue, Suite 400
Cambridge, MA 02138
http://obsidiantx.com/

Obsidian Therapeutics is a biotechnology company developing next-generation cell and gene therapies with pharmacologic operating systems. Based upon founding work on destabilizing domains by Professor Thomas Wandless, a leading researcher in chemical and systems biology, Obsidian's lead programs are CAR-T products that incorporate controllable functions for enhanced safety and efficacy. Obsidian was founded in 2015 by Atlas Venture and is funded by a strong syndicate of venture investors.

Key Contact
Name
Michael Gilman
Title
CEO
E-Mail
Funding Events

Date
Amount
Type
Investors
Valuation
12/06/17 $49,500,000 Series A Alexandria Real Estate Equities
Amgen Business Development
Atlas Venture
ShangPharma Investment Group
Takeda Ventures
Vertex Ventures
undisclosed